Corvus Pharma Expects FY24 Net Cash Used In Operating Activities ~$24M-$27M, Resulting In Projected Cash Balance Of $31M-$34M At Dec. 31, 2024; Expects Cash To Find Operations Into Q4 2025
Corvus Pharma預計,24財年用於經營活動的淨現金約爲2400萬至2700萬美元,預計截至2024年12月31日的現金餘額爲3100萬至3,400萬美元;預計現金將在2025年第四季度投入運營